# Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)

> **NCT00523406** · PHASE3 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 40 (actual)

## Conditions studied

- Macular Degeneration

## Interventions

- **PROCEDURE:** Photodynamic therapy and intravitreal triamcinolone

## Key facts

- **NCT ID:** NCT00523406
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00523406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00523406, "Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00523406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*